Antiretroviral agents
Researchers from Mangosuthu University of Technology have shed light on the persistent inflammation in HIV-positive individuals, despite antiretroviral therapy (ART). The study, published in the African Journal of Laboratory Medicine, analyzed retrospective laboratory results from 275 individuals, aged 0-39 years, treated at a tertiary hospital in South Africa. The findings
Antiretroviral agents
Despite expanded access to antiretroviral therapy in China, AIDS remains a significant public health challenge. A recent study aimed to assess survival outcomes and identify factors influencing survival time among HIV/AIDS patients receiving antiretroviral therapy in Jiulongpo District, Chongqing. The research utilized data from 2012 to 2022 and employed
Adults
Recent research conducted at Imperial College London has made significant breakthroughs in the treatment of HIV/AIDS. The study assessed the effectiveness of the WHO-recommended first-line dolutegravir-based antiretroviral therapy (ART) in programmatic settings in low- and middle-income countries (LMICs). The research revealed that adults receiving this treatment achieved high viral
Antiretroviral agents
Researchers at the University of Porto have developed a novel mathematical model to capture the coinfection dynamics of HIV and SARS-CoV-2 under the influence of highly active antiretroviral therapy (HAART). The model takes into account the effect of HAART on both infections and derives the basic reproduction numbers for each
Adults
Recent research conducted at Imperial College London has made significant breakthroughs in the treatment of HIV/AIDS. The study assessed the effectiveness of the WHO-recommended first-line dolutegravir-based antiretroviral therapy (ART) in programmatic settings in low- and middle-income countries (LMICs). The research revealed that adults receiving this treatment achieved high viral
HIV
Researchers at Government Dental College and Research Institute in Karnataka, India, have conducted a study on the effects of HIV infection on oral epithelium in patients with and without highly active anti-retroviral therapy (HAART). The study found that retroviral infection and its treatment induce significant changes in oral epithelium, and
HIV
Recent research conducted at Imperial College London has made significant breakthroughs in the treatment of HIV/AIDS. The study assessed the effectiveness of the WHO-recommended first-line dolutegravir-based antiretroviral therapy (ART) in programmatic settings in low- and middle-income countries (LMICs). The research revealed that adults receiving this treatment achieved high viral
HIV
A new study highlights the challenges posed by low-level viremia in HIV/AIDS patients, even when they are receiving effective antiretroviral therapy. The study, conducted in Chongqing, China, shows that despite the use of effective antiretroviral therapy, low-level viremia remains a significant issue, with reported prevalence rates ranging from 10-46%
HIV
Recent research from Simon Fraser University has shed new light on the persistence of hypermutated proviruses in people living with HIV, despite antiretroviral therapy (ART). The study, published in the journal Virus Evolution, found that hypermutated proviruses, which arise from the action of host antiviral APOBEC3 proteins, are present in
